NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.95% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.10% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.06% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.97% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.62% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.96% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.79% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.40% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.39% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.28% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.24% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.08% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.98% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.88% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.54% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.34% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.29% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.94% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.80% |